Fundly.ai, a fintech startup focused on the pharma industry, has raised $3 million in a seed funding round led by Accel India, along with participation from Multiply Ventures and undisclosed angel investors.
Founded in 2021, Fundly.ai provides credit financing and other solutions to players in the pharma distribution tail, speciality players, and brands. Beyond this, it aims to build a one-stop platform with a fusion of supply chain and MSME financing solutions to optimize the pharma distribution operations for speciality players and brands in the APAC region.
Since its inception, the company claims to have empowered over 2000 retailers and 30 distributors across seven cities, disbursing funds worth over INR 800 million.
The startup plans to use the funds to develop new product offerings and expand its reach into untapped markets. The startup also plans to bring a more efficient and effective pharma supply chain technology to a larger demographic.